BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31290773)

  • 1. Using pharmacogenetics in primary care.
    Murfin M
    JAAPA; 2019 Aug; 32(8):17-21. PubMed ID: 31290773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.
    Kim S; Yun YM; Chae HJ; Cho HJ; Ji M; Kim IS; Wee KA; Lee W; Song SH; Woo HI; Lee SY; Chun S
    Ann Lab Med; 2017 Mar; 37(2):180-193. PubMed ID: 28029011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in pregnancy.
    Betcher HK; George AL
    Semin Perinatol; 2020 Apr; 44(3):151222. PubMed ID: 32081407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics: introduction and use in clinical practice.
    Saunders H; Harris D; Chirilă RM
    Rom J Intern Med; 2020 Jun; 58(2):69-74. PubMed ID: 32074077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
    Cavallari LH; Mason DL
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 7. Is Pharmacogenetics Useful in Antidepressant Treatment?
    Fabbri C; Serretti A
    Clin Pharmacol Ther; 2019 Nov; 106(5):916-918. PubMed ID: 31584716
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Outcomes and Sustainability of Using
    Lee CR; Sriramoju VB; Cervantes A; Howell LA; Varunok N; Madan S; Hamrick K; Polasek MJ; Lee JA; Clarke M; Cicci JD; Weck KE; Stouffer GA
    Circ Genom Precis Med; 2018 Apr; 11(4):e002069. PubMed ID: 29615454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
    Fedorinov DS; Mirzaev KB; Ivashchenko DV; Temirbulatov II; Sychev DA; Maksimova NR; Chertovskih JV; Popova NV; Tayurskaya KS; Rudykh ZA
    Drug Metab Pers Ther; 2018 Jun; 33(2):91-98. PubMed ID: 29738309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
    Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
    Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roadmap for Routine Pharmacogenetic Testing in a Psychiatric University Hospital.
    Menke A; Weber H; Deckert J
    Pharmacopsychiatry; 2020 Jul; 53(4):179-183. PubMed ID: 31185510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of cardiovascular pharmacogenetics.
    Voora D; Ginsburg GS
    J Am Coll Cardiol; 2012 Jul; 60(1):9-20. PubMed ID: 22742397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patients.
    Ratner L; Zhu J'; Gower MN; Patel T; Miller JA; Cipriani A; Stouffer GA; Crona DJ; Lee CR
    Pharmacogenomics; 2022 Feb; 23(3):183-194. PubMed ID: 35083934
    [No Abstract]   [Full Text] [Related]  

  • 15. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
    Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementing a personalized medicine program in a community health system.
    Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
    Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics for Primary Care: An Overview.
    Rollinson V; Turner R; Pirmohamed M
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
    Miller DB; O'Callaghan JP
    Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.